Aptiganel

CAS No. 137159-92-3

Aptiganel( —— )

Catalog No. M34164 CAS No. 137159-92-3

Aptiganel (CNS-1102) is a non-competitive NMDA antagonist, a peptide that may be used to study acute ischemic stroke.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 686 In Stock
10MG 938 In Stock
25MG 1444 In Stock
50MG 1841 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Aptiganel
  • Note
    Research use only, not for human use.
  • Brief Description
    Aptiganel (CNS-1102) is a non-competitive NMDA antagonist, a peptide that may be used to study acute ischemic stroke.
  • Description
    Aptiganel (CNS 1102 (free base)), peptide, is a noncompetitive NMDA antagonist with cerebroprotective effects. Aptiganel can be used for the research of stroke.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    NMDAR
  • Recptor
    NMDAR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    137159-92-3
  • Formula Weight
    303.4
  • Molecular Formula
    C20H21N3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N=C(NC1=CC=CC=2C=CC=CC21)N(C3=CC=CC(=C3)CC)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Meadows ME, et al. Delayed treatment with a non-competitive NMDA antagonist, CNS-1102 reduces infarct size in rats. Cerebrovasc Dis.1994;4:26-31.
molnova catalog
related products
  • Procyclidine hydroch...

    Procyclidine is a potent anticholinergic agent and also have NMDA antagonist properties.

  • BZAD01

    BZAD01 is a selective NMDA NR1A/2B receptor antagonist.

  • Ro 25-6981 Maleate

    Ro 25-6981 Maleate is a potent and selective activity-dependent NMDA receptor blocker, specifically targeting the NR2B subunit (IC50 values are 0.009 μM for NR1C/NR2B and 52 μM for NR1C/NR2A receptor subunit combinations).